Cleared Traditional

K250454 - HardyDisk Aztreonam/Avibactam 30/20µg (AZA50) (FDA 510(k) Clearance)

May 2025
Decision
86d
Days
Class 2
Risk

K250454 is an FDA 510(k) clearance for the HardyDisk Aztreonam/Avibactam 30/20µg (AZA50). This device is classified as a Susceptibility Test Discs, Antimicrobial (Class II - Special Controls, product code JTN).

Submitted by Hardy Diagnostics (Santa Maria, US). The FDA issued a Cleared decision on May 15, 2025, 86 days after receiving the submission on February 18, 2025.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1620.

Submission Details

510(k) Number K250454 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2025
Decision Date May 15, 2025
Days to Decision 86 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code JTN — Susceptibility Test Discs, Antimicrobial
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1620

Similar Devices — JTN Susceptibility Test Discs, Antimicrobial

All 7
HardyDisk AST Cefiderocol 30µg (FDC30)
K253105 · Hardy Diagnostics · Nov 2025
HardyDisk AST Gepotidacin 10µg (GEP10)
K250956 · Hardy Diagnostics · Jun 2025
HardyDisk AST Cefiderocol 30µg (FDC30)
K241060 · Hardy Diagnostics · Jul 2024
HardyDisk AST Sulbactam/Durlobactam 10/10µg (SUD20)
K231568 · Hardy Diagnostics · Jul 2023
BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)
K230651 · Becton, Dickinson and Company · Jun 2023
HardyDisk AST Rezafungin 5µg (RZF5)
K230827 · Hardy Diagnostics · Jun 2023